Vaccine Delivery has become very Important Part of Medical Device Industry

Vaccine Delivery has become a major topic in bioscience and medicine recently. We’ve had a front-row seat to influential research in this subject at Product Creation Studio. While we aren’t vaccine or microbiology specialists, we do have some experience with user-centered design in drug delivery and other healthcare operations. We frequently assist innovative researchers in turning their discoveries into commercially viable products.

Other medical device professionals could find stories from this type of work intriguing, I realised. While these projects are not without their difficulties, who wouldn’t want to support forward-thinking endeavours that could have a significant impact on healthcare? I’ve decided to share some of our experiences in the hopes that they would be useful to others working in the field of scientific translation.

Deborah Fuller is a microbiologist who studies next-generation vaccines and Vaccine Delivery at the University of Washington. She had been telling us about the possibility of nucleic acid vaccines (including mRNA) before to the pandemic, but it seemed like a long way off. As COVID spread, I had the opportunity to speak with Deb about the distinctions between self-amplifying RNA, DNA, and mRNA vaccine technologies, and I discovered how knowledgeable she is about Vaccine Delivery.As a mechanical engineer, I thought it was fascinating since most of her research revolved around an unique electro-mechanical apparatus known as a gene gun.

Orlance, her spin-off firm, is developing a revolutionary delivery system that uses a controlled burst of pressurised helium to propel tiny, specially treated gold particles toward specific areas.With low dose requirements, room-temperature doses, and needle-free, painless delivery, this provides a very flexible delivery platform. However, this is not the ubiquitous and familiar syringe format; new systems and procedures must be developed in tandem with the vaccinations in order to fully utilise the technology. Our team has aided them in not just achieving the needed pneumatic pulses, but also in considering workflows and what a clinical gene gun may seem.